Talk:List of largest biomedical companies by revenue

Net profit
Hello, Wouldn't it be helpful to add the net profit of the companies to the list for the purpose of better comparison? If so, I could help to add these informations. Thanks for reading. — Preceding unsigned comment added by GentianB (talk • contribs) 14:56, 26 March 2018 (UTC)

Danaher
Why is Danaher on this list? They bought a tools company from GE, not a drug company.98.184.199.149 (talk) 15:15, 20 May 2019 (UTC)
 * from CBS's Marketwatch stock page for Danaher, NOT a drug company: "Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC. " 2600:1012:B045:5337:44C4:FF3E:5AC3:ECF0 (talk) 16:45, 24 June 2019 (UTC)

Abbott
Why is Abbott on this list - Abbott basically split off AbbVie long ago for the main part of its pharmaceutical business. Abbott's business now is like $4B in drug revenue with a ton of device and diagnostic stuff making up the bulk. This list isn't going to be very useful if it uses a company's overall revenue to determine position rather than the company's actual drug revenue. 98.184.199.149 (talk) 14:39, 22 May 2019 (UTC)


 * With the consolidation wave taking place within Pharma, Biotechs, Medical device and Healthcare companies the scope of this article should be widened. J&J for example span multiple categories but it wouldn't make sense to hive off each business segment into something separate. XyZAn (talk) 21:45, 27 June 2019 (UTC)


 * I'm in the industry and it would not be useful to me or others to do that. Not enough overlap.  A list of drug companies has specific utility.  Plus this is not how the information is compiled in the business press; nor are these companies listed together on financial websites.  They are considered separate industry verticals.


 * Now, we do need to deal with J&J's mixed revenue, I don't think that's addressed well. But if you want a list with Danaher, Thermo Fisher, etc on it, why make this list less useful rather than starting a page with all medical-related companies on it?  There are a billion that have nothing to do with drugs: Stryker, Medtronic, Cardinal Health, VWR, yadda yadda.  98.184.199.149 (talk) 13:41, 1 July 2019 (UTC)


 * So, we need to move this forward. Your proposal is to widen the scope of the page to be a list of largest biomedical companies by revenue.  I am fine with that.  Let's change the name of the page to "List of largest biomedical companies by revenue" if you like, and then add the other companies in that become relevant.  Then because it has specific utility a page of pharma companies is still appropriate in parallel.  The two things don't stand in opposition, they work together fine.  But the current state is an inaccurate page that lists non-pharma companies as some of the "largest pharmaceutical companies by revenue" and that needs to change soon.  98.184.199.149 (talk) 14:27, 5 July 2019 (UTC)


 * Agreed, I will move the page. Would it also be worth a foot note for each company specifying what 'type' it falls under? Again flexible on that, just think it would be a way clarifying whether Company A is a pharma, biotech, medical device etc.. XyZAn (talk) 21:16, 5 July 2019 (UTC)


 * Yes, I think that's helpful. A foot note or an additional column.  It could list various categories of revenue that combine for the total.  I would say that the major ones would be pharmaceuticals, medical devices, consumer goods (those first three pretty much cover J&J), biomedical research products and services, and other.98.184.199.149 (talk) 05:43, 12 July 2019 (UTC)

Sorting function for the list is not working properly
Under the "Top pharmaceutical companies with revenue greater than $10 billion" section, the sort for the 2019 column is going by the first numbers, not the full numbers. For example, when set to sort in ascending order, the order of the numbers is: 2.79 (Labcorp); 20.2 (Johnson & and Johnson); 3.49 (Biogen). Johnson & Johnson, at 20.2, should come well further down the list after Biogen, which is at 3.49. As far as I could tell, this error only occurs with the 2019 column. Hope I made sense, thank you! JusInBello 19:53, 30 June 2019 (UTC)